Biomerica, Inc.
BMRA Healthcare Medical Devices
Biomerica, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $4.5 million, down 16.2% from fiscal 2025. In the quarter to May 2026, revenue grew 17.0%, EPS grew 37.8% and free cash flow fell 35.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow BMRA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
3.05 | 2.54 | 1.34 | 1.31 |
Receivables |
1.21 | 0.95 | 0.94 | 0.79 | |
Inventory |
1.47 | 1.52 | 1.65 | 1.71 | |
Total current assets |
5.90 | 5.19 | 4.12 | 4.02 | |
Property, Plant, Equpment (Net) |
0.12 | 0.11 | 0.09 | 0.08 | |
Long-Term Investments |
0.17 | 0.17 | 0.17 | 0.50 | |
Goodwill and Intangible Assets (Total) |
0.22 | 0.22 | 0.23 | 0.21 | |
Long-term assets (Other) |
0.10 | 0.09 | 0.09 | 0.08 | |
Total non-current assets |
0.96 | 0.84 | 0.76 | 2.74 | |
Total Assets |
6.85 | 6.03 | 4.88 | 6.76 | |
Notes Payable |
— | — | — | 0.50 | |
Accounts Payable |
0.68 | 0.74 | 0.73 | 1.17 | |
Accrued Expenses |
0.59 | 0.55 | 0.61 | 0.49 | |
Total current liabilities |
1.69 | 1.60 | 1.56 | 2.48 | |
Total non-current liabilities |
0.01 | — | — | 1.65 | |
Total liabilities |
1.70 | 1.60 | 1.56 | 4.13 | |
Additional Paid In Capital |
58.20 | 58.79 | 58.98 | 59.43 | |
Common Stock (Net) |
0.23 | 0.24 | 0.24 | 0.26 | |
Retained Earnings |
(53.17) | (54.49) | (55.80) | (56.94) | |
Common Equity (Total) |
5.16 | 4.44 | 3.32 | 2.63 | |
Shareholders Equity (Total) |
5.16 | 4.44 | 3.32 | 2.63 | |
Shareholders Equity and Liabilities (Total) |
6.85 | 6.03 | 4.88 | 6.76 | |
Shares (Common) |
2.82 | 2.95 | 3.03 | 3.20 | |
Shareholders Equity (Tangible) |
4.93 | 4.22 | 3.09 | 2.42 | |
Net Debt |
(3.05) | (2.54) | (1.34) | (1.31) |